October 5, 2020 Artoss, Inc. Announces Record Sales of NanoBone Bone Graft »
​
April 24, 2019 Artoss, Inc. Announces FDA Clearance of NanoBone SBX Putty for Standalone Use in Posterolateral Spinal Fusion »
​
March 28, 2019 Artoss, Inc. Announces Hiring of Gabriel "Gabe" Ortiz as Director of Sales, Western Region
​
September 24, 2018 Artoss, Inc. Announces Hiring of William “Billy” Lapp as Director of Sales, East Coast. Further expansion of U.S. presence supporting commercialization
​
September 24, 2018 Artoss Announces Completion of $1 Million Funding Round. Financing allows expanded U.S. commercial and clinical presence
​
October 23, 2017 Artoss Announces NanoBone® QD Bone Graft. NanoBone QD allows for expanded orthopaedic clinical use
​
October 9, 2017 Artoss, Inc. Announces Hiring of Ryan O’Neill as Director of Sales, Eastern Region. Experienced Sales Background Supports NanoBone Efforts
​
September 15, 2017 Artoss, Inc. Announces DAPA Agreement for NanoBone® Bone Graft Products. Expands NanoBone U.S. Commercial Opportunities
​
November 8, 2016 Artoss Announces FDA Clearance to Market of NanoBone SBX Putty. Clearance Expands NanoBone role in U.S. Orthopaedic Surgery
